Lite Strategy
LITS0.98023.04% ( +0.0289 )
Lite Strategy (LITS)
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The c...
- Open
- 0.9500
- High
- 0.9989
- Low
- 0.9500
- Prev. Close
- 0.9513
- Volume
- 104.62K
- Turnover
- 102.18K
- Avg Price
- 0.9766
- Bid/Ask Ratio
- --
- Amplitude
- 5.14%
- 52wk High
- 5.5480
- Volume Ratio
- 0.53
- Turnover Ratio
- 0.40%
Lite Strategy Analyst Rating
View MoreForecast & Rating
Feb 13, 2025Price forecast
$20.001940.40%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · Jul 24 at 04:52 PM
Lite Strategy Unveils Litecoin-Focused Investor Strategy Update
- TradingView · Jul 24 at 04:33 PM
Lite Strategy readies investor deck, discloses 830,378 LTC treasury, $25M buyback plan
- PUBT · Jun 25 at 03:30 PM
Lite Strategy director James P. Flynn reports purchase of USD 21,387.50 in common shares
- CoinLive · Jun 19 at 09:23 AM
Lite Strategy Leads $1 Million Strategic Investment in LitVM
- StockTitan · Jun 18 at 11:30 PM
Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam | LITS Stock News
- PUBT · Jun 18 at 07:31 AM
Lite Strategy invests $1 million in LitVM developer ZK Innovations
